Exercise May Lower Clotting Risk in Patients With NASH

TUESDAY, March 8, 2022 (HealthDay News) -- Exercise may help patients with nonalcoholic steatohepatitis (NASH) reduce their risk for developing blood clots, according to a study recently published in Hepatology.
Jonathan G. Stine, M.D., from Pennsylvania State University in Hershey, and colleagues randomly assigned patients with biopsy-confirmed NASH to either an exercise training program (18 patients) or standard clinical care (10 patients).
The researchers found that the plasminogen activator inhibitor 1 level was significantly decreased with exercise training versus standard clinical care (−40 versus +70 ng/mL). Exercise training was also associated with decreased magnetic resonance imaging proton density fat fraction (MRI-PDFF), with 40 percent of exercise participants having a ≥30 percent relative reduction in MRI-PDFF (histological response threshold) versus 13 percent among those receiving standard of care. Lastly, exercise training was associated with improved fitness (as measured by VO2 peak) versus standard clinical care.
"Independent of weight loss or dietary change, exercise training resulted in a significantly greater decrease in thrombotic risk than standard clinical care in patients with NASH," the authors write.
One author disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Suicide Attempts, Suicide Mortality Up for Transgender Individuals
FRIDAY, June 30, 2023 (HealthDay News) -- Transgender individuals have increased...
FDA Approves First RSV Vaccine
WEDNESDAY, May 3, 2023 (HealthDay News) -- The first vaccine for respiratory...
Shorter Menstrual Cycles May Affect Timing of Menopause
THURSDAY, Aug. 25, 2022 (HealthDay News) -- The length of your monthly menstrual...
La ciencia ofrece nuevas perspectivas sobre los orígenes del TOC
VIERNES, 30 de junio de 2023 (HealthDay News) -- La Dra. Carolyn Rodríguez, una...